Close
ACHEMA MIDDLE EAST 2026

Nanoparticles : Next Frontier In Pharmaceutical Innovations

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of unfulfilled requirements, and the...

Nickel Complex Innovations Streamlines Drug Development

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical business new ways to...

Streamlining Toxicology Materials For IND And FIH Studies

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in the supply of toxicological data...

Booming Radiopharmaceuticals Industry Attracts Investors

The radiopharmaceutical industry is growing very quickly. In the past few years, there have been more mergers and acquisitions (M&A) and partnerships. Investors can...

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion agreement last...

Bayer, NextRNA Collaborate On $547Million Cancer Drug Deal

Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of small molecule cancer drug....

Enhancing CLD For Complex Biologics: Important Strategies

The capacity of a cell line to create a biologic that is both safe and stable in large numbers may be considerably improved by...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...